4
Changes in Ownership
Transcode Therapeutics, Inc. Filed Acc 0001104659-23-105925
Chief Financial Officer bought 49,350 shares at $0.51 ($25,169)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fitzgerald Thomas A Chief Financial Officer | 2023-09-28 | Purchase | +49,350 | $0.51 | $25,169 | 56,318 | D |
| Open-market purchases · 49,350 sh · avg $0.51 · $25,169 | |||||||
Loading xslF345X05/tm2327413d2_4seq1.xml…